Suboptimal <scp>COVID</scp>‐19 vaccine uptake among hospitalised patients

Sookaromdee, Pathum; Viroj, Wiwanitkit

doi:10.1111/imj.15771

Cited by 2 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The study’s main limitation was its focus on the Alpha variant, excluding others like Delta or Omicron [ 39 ]. A separate study at the Royal Adelaide Hospital found that 24% of inpatients had not received any COVID-19 vaccine doses, indicating suboptimal vaccine uptake among a high-risk group [ 40 ]. In our cohort, more than 48% of patients had not been vaccinated, attributed to concerns over side effects, effectiveness, insufficient testing, mistrust in authorities, and conspiracy theories [ 41 , 42 ].…”

Section: Discussionmentioning

confidence: 99%

Vaccine Effectiveness against SARS-CoV-2 Infection during the Circulation of Alpha, Delta, or Omicron Variants: A Retrospective Cohort Study in a Tertiary Hospital in Serbia

Đurić-Petković,

Šuljagić,

Begović-Kuprešanin

et al. 2024

Vaccines

View full text Add to dashboard Cite

The COVID-19 pandemic prompted rapid vaccine development and deployment worldwide. Despite widespread vaccination efforts, understanding the effectiveness of vaccines in hospitalized patients remains a critical concern. This retrospective cohort study, conducted at a tertiary healthcare centre in Serbia, tracked patients hospitalized during different waves of COVID-19 variants—Alpha, Delta, and Omicron. Data collection included demographics, comorbidities, symptoms, and vaccination status. Among 3593 patients, those with prior exposure to COVID-19 cases or hospital treatment showed higher positivity rates. Symptom prevalence varied across waves, with coughs persisting. Patients without chronic diseases were more frequent among those testing negative. Vaccine effectiveness varied, with Sinopharm demonstrating a 45.6% effectiveness initially and Pfizer-BioNTech showing an effectiveness of up to 74.8% within 0–84 days after the second dose. Mixed-dose strategies, notably Sinopharm as a primary dose followed by a Pfizer-BioNTech booster, suggested increased protection. Despite substantial vaccination availability, a significant portion of hospitalized patients remained unvaccinated. This study underscores the dynamic nature of vaccine effectiveness and advocates for booster strategies to address evolving challenges in combating COVID-19, particularly in hospitalized patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Vaccine Effectiveness against SARS-CoV-2 Infection during the Circulation of Alpha, Delta, or Omicron Variants: A Retrospective Cohort Study in a Tertiary Hospital in Serbia

Đurić-Petković,

Šuljagić,

Begović-Kuprešanin

et al. 2024

Vaccines

View full text Add to dashboard Cite

show abstract

“…3 There have been initiatives to increase COVID-19 vaccination rates at outpatient, community and larger healthcare settings. [4][5][6] While there is a plethora of literature and debate surrounding the COVID-19 vaccination and the lack of COVID-19 vaccine uptake in hospitalised setting, [7][8][9] there is-to the best of our knowledge-only one report from Freiser et al that describes QI interventions implemented in the hospital setting to improve COVID-19 vaccination rates among hospitalised patients 10 and no reports on hospitalist-initiated measures to improve in-patient vaccination rates.…”

Section: Introductionmentioning

confidence: 99%

Can hospitalists improve COVID-19 vaccination rates?

Yu,

Punatar,

Shaikh

et al. 2024

BMJ Open Qual

View full text Add to dashboard Cite

Three years after the start of the SARS-CoV-2 virus (COVID-19) pandemic, its effects continue to affect society and COVID-19 vaccination campaigns continue to be a topic of controversy and inconsistent practice. After experiencing spikes in COVID-19 cases, our University of California Davis Health Division of Hospital Medicine sought to understand the reasons underlying the low COVID-19 vaccination rates in our county and find approaches to improve the number of vaccinations among adults admitted to the inpatient setting. This quality improvement project aimed to increase COVID-19 primary and booster vaccine efforts through a multi-pronged approach of increased collaboration with specialised staff and optimisation of use of our electronic health record system.Our key interventions focused on developing a visual reminder of COVID-19 vaccine status using the functionality of our electronic medical record (EMR), standardising documentation of COVID-19 vaccine status and enhancing team-based vaccination discussions through team huddles and partnering with inpatient care coordinators. While our grassroots approach enhanced COVID-19 vaccination rates in the inpatient setting and had additional benefits such as increased collaboration among teams, system-level efforts often made a greater impact at our healthcare centre. For other institutions interested in increasing COVID-19 vaccination rates, our top three recommendations include integrating vaccination into pre-existing workflows, optimising EMR functionality and increasing vaccine accessibility in the inpatient setting.

show abstract

Suboptimal COVID‐19 vaccine uptake among hospitalised patients

Cited by 2 publications

References 4 publications

Vaccine Effectiveness against SARS-CoV-2 Infection during the Circulation of Alpha, Delta, or Omicron Variants: A Retrospective Cohort Study in a Tertiary Hospital in Serbia

Vaccine Effectiveness against SARS-CoV-2 Infection during the Circulation of Alpha, Delta, or Omicron Variants: A Retrospective Cohort Study in a Tertiary Hospital in Serbia

Can hospitalists improve COVID-19 vaccination rates?

Contact Info

Product

Resources

About